STAAR Surgical Company (STAA) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
Total Assets Chart for STAAR Surgical Company
STAAR Surgical Company (STAA) total assets for FY2025 were USD 461.6M, a -9.4% change from FY2024. STAAR Surgical Company's total assets grew from USD 16.1M in 1988 to USD 461.6M in 2025 (2767.2% over 37 years). Total assets compound annual growth rate: 5-year CAGR of 12.4%, 10-year CAGR of 22.0%, 20-year CAGR of 11.5%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.13B
- Implied Share Price
- $22.61
- Enterprise Value
- $1.32B
- Revenue (TTM)
- $339.59M
- EBITDA
- $49.76M
- Profit Margin
- 1.13%
- Trailing P/E
- 282.62
- Forward P/E
- 126.58
- Price/Book (MRQ)
- 4.11
- Price/Sales (TTM)
- 3.34
- EV/EBITDA
- 89.62
- EV/Revenue
- 4.55
- Dividend Yield
- —
- Book Value
- $7.29
- Free Cash Flow (FY2025)
- -$40.05M
- Free Cash Flow Yield
- -3.53%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.